vs
Cytek Biosciences, Inc.（CTKB）与Ponce Financial Group, Inc.（PDLB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Ponce Financial Group, Inc.的2.0倍（$62.1M vs $31.4M），Ponce Financial Group, Inc.净利率更高（36.3% vs -70.9%，领先107.2%），Ponce Financial Group, Inc.同比增速更快（37.6% vs 8.1%），Ponce Financial Group, Inc.自由现金流更多（$54.6M vs $-1.8M），过去两年Ponce Financial Group, Inc.的营收复合增速更高（23.7% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
庞塞金融集团是总部位于美国的金融控股公司，核心子公司为庞塞银行，主要服务纽约大都会区的多元文化、移民及中低收入社区，提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
CTKB vs PDLB — 直观对比
营收规模更大
CTKB
是对方的2.0倍
$31.4M
营收增速更快
PDLB
高出29.5%
8.1%
净利率更高
PDLB
高出107.2%
-70.9%
自由现金流更多
PDLB
多$56.4M
$-1.8M
两年增速更快
PDLB
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $31.4M |
| 净利润 | $-44.1M | $10.1M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 43.6% |
| 净利率 | -70.9% | 36.3% |
| 营收同比 | 8.1% | 37.6% |
| 净利润同比 | -557.1% | 245.6% |
| 每股收益（稀释后） | — | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBPDLB
| Q4 25 | $62.1M | $31.4M | ||
| Q3 25 | $52.3M | $26.7M | ||
| Q2 25 | $45.6M | $26.5M | ||
| Q1 25 | $41.5M | $24.6M | ||
| Q4 24 | $57.5M | $22.8M | ||
| Q3 24 | $51.5M | $20.2M | ||
| Q2 24 | $46.6M | $20.2M | ||
| Q1 24 | $44.9M | $20.5M |
净利润CTKBPDLB
| Q4 25 | $-44.1M | $10.1M | ||
| Q3 25 | $-5.5M | $6.5M | ||
| Q2 25 | $-5.6M | $6.1M | ||
| Q1 25 | $-11.4M | $6.0M | ||
| Q4 24 | $9.6M | $2.9M | ||
| Q3 24 | $941.0K | $2.4M | ||
| Q2 24 | $-10.4M | $3.2M | ||
| Q1 24 | $-6.2M | $2.4M |
毛利率CTKBPDLB
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBPDLB
| Q4 25 | -9.0% | 43.6% | ||
| Q3 25 | -17.6% | 32.8% | ||
| Q2 25 | -23.3% | 30.2% | ||
| Q1 25 | -36.1% | 32.5% | ||
| Q4 24 | 5.2% | 19.6% | ||
| Q3 24 | -8.2% | 15.2% | ||
| Q2 24 | -18.3% | 21.8% | ||
| Q1 24 | -23.9% | 18.3% |
净利率CTKBPDLB
| Q4 25 | -70.9% | 36.3% | ||
| Q3 25 | -10.5% | 24.3% | ||
| Q2 25 | -12.2% | 23.0% | ||
| Q1 25 | -27.5% | 24.2% | ||
| Q4 24 | 16.8% | 14.1% | ||
| Q3 24 | 1.8% | 12.1% | ||
| Q2 24 | -22.4% | 15.8% | ||
| Q1 24 | -13.8% | 11.8% |
每股收益（稀释后）CTKBPDLB
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $0.27 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $126.2M |
| 总债务越低越好 | — | $596.1M |
| 股东权益账面价值 | $341.7M | $541.5M |
| 总资产 | $461.5M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势，按日历期对齐
现金及短期投资CTKBPDLB
| Q4 25 | $90.9M | $126.2M | ||
| Q3 25 | $93.3M | $146.6M | ||
| Q2 25 | $75.5M | $126.6M | ||
| Q1 25 | $95.3M | $129.9M | ||
| Q4 24 | $98.7M | $139.8M | ||
| Q3 24 | $162.3M | $155.8M | ||
| Q2 24 | $177.9M | $103.2M | ||
| Q1 24 | $168.8M | $134.7M |
总债务CTKBPDLB
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
股东权益CTKBPDLB
| Q4 25 | $341.7M | $541.5M | ||
| Q3 25 | $378.6M | $529.8M | ||
| Q2 25 | $377.6M | $521.1M | ||
| Q1 25 | $379.6M | $513.9M | ||
| Q4 24 | $395.7M | $505.5M | ||
| Q3 24 | $385.5M | $504.6M | ||
| Q2 24 | $389.1M | $497.7M | ||
| Q1 24 | $392.6M | $493.7M |
总资产CTKBPDLB
| Q4 25 | $461.5M | $3.2B | ||
| Q3 25 | $494.9M | $3.2B | ||
| Q2 25 | $493.3M | $3.2B | ||
| Q1 25 | $482.6M | $3.1B | ||
| Q4 24 | $499.5M | $3.0B | ||
| Q3 24 | $491.2M | $3.0B | ||
| Q2 24 | $483.7M | $2.8B | ||
| Q1 24 | $492.1M | $2.8B |
负债/权益比CTKBPDLB
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $55.6M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $54.6M |
| 自由现金流率自由现金流/营收 | -2.9% | 173.9% |
| 资本支出强度资本支出/营收 | 1.6% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 5.48× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $74.3M |
8季度趋势，按日历期对齐
经营现金流CTKBPDLB
| Q4 25 | $-771.0K | $55.6M | ||
| Q3 25 | $-3.9M | $1.4M | ||
| Q2 25 | $108.0K | $6.2M | ||
| Q1 25 | $-125.0K | $13.1M | ||
| Q4 24 | $2.0M | $7.2M | ||
| Q3 24 | $13.2M | $-14.6M | ||
| Q2 24 | $6.2M | $-2.6M | ||
| Q1 24 | $4.0M | $1.5M |
自由现金流CTKBPDLB
| Q4 25 | $-1.8M | $54.6M | ||
| Q3 25 | $-4.6M | $786.0K | ||
| Q2 25 | $-1.5M | $5.9M | ||
| Q1 25 | $-974.0K | $12.9M | ||
| Q4 24 | $1.1M | $4.5M | ||
| Q3 24 | $12.2M | $-15.0M | ||
| Q2 24 | $5.2M | $-2.6M | ||
| Q1 24 | $3.4M | $-315.0K |
自由现金流率CTKBPDLB
| Q4 25 | -2.9% | 173.9% | ||
| Q3 25 | -8.7% | 2.9% | ||
| Q2 25 | -3.2% | 22.4% | ||
| Q1 25 | -2.3% | 52.6% | ||
| Q4 24 | 1.9% | 19.7% | ||
| Q3 24 | 23.7% | -74.1% | ||
| Q2 24 | 11.0% | -13.0% | ||
| Q1 24 | 7.6% | -1.5% |
资本支出强度CTKBPDLB
| Q4 25 | 1.6% | 3.1% | ||
| Q3 25 | 1.3% | 2.3% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 11.9% | ||
| Q3 24 | 2.0% | 2.0% | ||
| Q2 24 | 2.3% | 0.3% | ||
| Q1 24 | 1.3% | 8.7% |
现金转化率CTKBPDLB
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 0.21× | 2.46× | ||
| Q3 24 | 14.05× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PDLB
暂无分部数据
